Emerging Biomarkers for Lupus

ATLANTA—When it comes to identifying reliable biomarkers that can predict worsening illness or help point to proper treatment, it’s hard to imagine a more vexing disease than systemic lupus erythematosus (SLE), said Jill P. Buyon, MD, director of the Lupus Center at New York University Langone Medical Center, in the 2019 ACR/ARP Annual Meeting session... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions SLE (Lupus) 2019 ACR/ARP Annual Meeting Biomarkers Research Source Type: research